GENENTA SCIENCE S.P.A.

4.6950

26-November-24 14:48:17

15 minutes delayed

Stocks

-0.0950

-1.98%

Today's range

4.6900 - 4.9000

ISIN

N/A

Source

NASDAQ

Genenta Progresses to Higher Dosing Cohort in Temferon™ Phase 1/2a Clinical Trial in Glioblastoma Multiforme

04 May 2022 07:30:00 By Nasdaq GlobeNewswire
Genenta Announces Nomination of Mark A. Sirgo as Chair

27 Apr 2022 07:30:00 By Nasdaq GlobeNewswire
Genenta to Host Expert Fireside Chat on Immuno Gene & Cell Therapy for Treatment of Solid Tumors

20 Apr 2022 07:30:00 By Nasdaq GlobeNewswire
Genenta Data Presentation at AACR to Describe On-Target Biological Activity of Temferon™ in Unmethylated Glioblastoma Multiforme

09 Mar 2022 07:46:22 By Nasdaq GlobeNewswire
Genenta to Participate at Upcoming Investor Conferences

24 Feb 2022 07:30:01 By Nasdaq GlobeNewswire
Genenta Closes Its Upsized Initial Public Offering of American Depository Shares

17 Dec 2021 16:15:00 By Nasdaq GlobeNewswire
Genenta Announces Pricing of Upsized Initial Public Offering

14 Dec 2021 22:36:29 By Nasdaq GlobeNewswire

<<
<
1
2
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.